LY2090314

LY2090314 is a potent GSK-3 inhibitor for GSK-3α/β with IC50 of 1.5 nM/0.9 nM; may improve the efficacy of platinum-based chemotherapy regimens.

Specifications & Purity: LY2090314 is a potent GSK-3 inhibitor for GSK-3α/β with IC50 of 1.5 nM/0.9 nM; may improve the efficacy of platinum-based chemotherapy regimens.

Grade: Moligand™

Molecular Formula: C28H25FN6O3

Molecular Weight: 512.53

EC Number: 110-218-9

PubChem CID: 10029385

Isomeric SMILES: C1CCN(CC1)C(=O)N2CCN3C=C(C4=CC(=CC(=C43)C2)F)C5=C(C(=O)NC5=O)C6=CN=C7N6C=CC=C7

Storage Temperature: Store at -20°C

Shipped in: Ice chest + Ice pads

More Information: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/L126079-SCI_f7db3c794397af0fe6c2ce10206dd6a4.pdf

UPC:

41116127

Weight:

1.06 Ounces

HazmatClass:

Yes

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

L126079-1mg

Country of Origin:

China

CAS:

603288-22-8

Product Size:

1mg

Harmonized Tariff Code:

2931.90.90